Proline-, glutamic acid- and leucine-rich protein-1 (PELP1), a scaffolding oncogene, is highly correlated with cancer progression and outcomes for patients with advanced ESCC. The gene discussed is PELP1; the disease is esophageal squamous cell carcinoma.